Morning Watchlist

    Four retailers to watch this week - 8/17

    Behind the Markets
    Monday, August 17, 2026
    Four retailers to watch this week - 8/17

    Morning Watchlist: Monday Edition             

    A quick note from Behind the Markets

    Wall Street heads into Monday feeling comfortable. Stocks are near records after a week of well-behaved inflation data — consumer prices in line, producer prices flat — and the Fed has gone quiet ahead of its September meeting.

    That is exactly when independent investors should hunt for the risk nobody is pricing.

    Here's the tell from Friday. Applied Materials reported the best quarter in its history — record revenue, record earnings, and a raised outlook — and the stock fell about 5%. Nothing was wrong with the business. Everything was wrong with what had already been assumed about it.

    That's a market that has stopped paying for good news and started demanding perfect news. This week, the clues are in the yen, the semiconductor aisle, the retail aisle, and a Federal Reserve survey that doesn't exist yet.


    1) The Yen Is the Hidden Fuse Under the AI Rally

    Reports on Friday indicated the Bank of Japan could raise rates as soon as September. That's not a done deal, but the supporting evidence has been stacking up for weeks, and it deserves more weight than a currency headline usually gets.

    Here's where policy actually stands. The BOJ raised its rate to 1.0% in June — the highest since September 1995 — and held there in July on an 8-1 vote, with one board member dissenting in favor of going higher. Japanese producer prices are running at 7.2% year over year. The government has now publicly signaled support for a near-term hike, with the next move expected in September or October. And the U.S. and Japan have already intervened jointly in the currency market to defend the yen, which prompted Bank of America to revise its year-end forecast to ¥149 per dollar and note that a successful defense "likely requires follow-through from macroeconomic policies: specifically, faster rate hikes."

    Now the part that matters for your portfolio, even if you don't own Japanese stocks directly.

    For most of two decades, the yen has been the world's funding currency — borrow cheaply in Tokyo, buy something with a higher return anywhere else. That trade works beautifully until the funding cost rises and the currency you borrowed in appreciates, at which point you're squeezed on both ends simultaneously and the exit is crowded. The first assets sold in that scramble are rarely the ones causing the problem. They're the liquid, profitable, widely-held positions — the ones investors swore they'd never sell — because those are the only things you can sell quickly at a fair price.

    So don't reduce this to a chart. Treat it as a positioning question: if global funding costs rise 100 basis points and the yen strengthens 6%, which of your holdings gets sold by someone else's margin clerk? That's a different question from whether your companies are good.

    Bottom line: Watch the yen as a funding signal, not a Japan story. The first victims of tighter global liquidity are usually the assets investors claimed they would never sell.

    📢 Sponsor Slot — rotating content will appear here

    2) Applied Materials Just Exposed the New AI Problem

    Applied Materials reported fiscal third-quarter results Wednesday after the close, and by any absolute standard they were superb: revenue of $9.115 billion, up 25% year over year and up 15% sequentially — the fastest quarter-over-quarter growth in the company's history — against roughly $8.99 billion expected. Non-GAAP earnings of $3.50 per share set a record and beat the $3.40 consensus. Operating cash flow hit a record $3.04 billion, free cash flow rose 14% to $2.33 billion, and the company returned $860 million to shareholders.

    Management then raised the calendar-2026 outlook substantially: semiconductor systems revenue growth now expected above 30%, up from a prior call of above 20%; global services above 20%; process diagnostics and control above 50%; advanced packaging above 70%.

    The stock fell about 5% to roughly $508.

    Why? Because it had already risen something like 200% into the print, trading near $541 with the market pricing perfection. Analysts pointed to elevated expectations rather than any operational problem — a textbook sell-the-news reaction. And there is one genuine structural concern underneath: China fell to about 28% of revenue from roughly 35% a year earlier. That's a real shift in the customer base, and while AI demand elsewhere has more than filled the gap so far, it's the number to track.

    This is the next phase of AI investing: a healthy industry is not the same as a healthy stock. When every participant in a supply chain is growing, the question becomes who keeps the economics after suppliers, rivals, and customers all demand a larger share.

    The Stock: Applied Materials (NASDAQ: AMAT)

    Here's why the sell-off is interesting rather than alarming. Applied is the largest semiconductor equipment maker in the world, and its moat is service revenue and switching costs. Applied Global Services — the recurring business of keeping installed tools running, which management expects to grow more than 20% this year — is the annuity underneath the equipment cycle. Chipmakers cannot casually qualify a replacement for deposition and etch tools already embedded in a production line; requalification costs time and yield, which is the most expensive currency in a fab.

    And after Friday, the valuation is the least demanding among the big four. Applied trades around 32 times forward earnings against roughly 34.6 for Lam Research, 36.9 for KLA, and 33.4 for ASML — the cheapest of the group, with the raised outlook now public.

    The other side, honestly. The stock is up roughly 200% and one pullback doesn't make it cheap in absolute terms — 32 times forward earnings is a full price for a cyclical business, and semiconductor capital equipment has always been cyclical no matter how permanent the current buildout feels. China concentration is falling, which cuts both ways: less geopolitical exposure, but also a shrinking customer base that AI demand must keep replacing. And the company's own history counsels patience — across its last five earnings beats the average reaction on the day has been negative, about −2.2%, with one 14% single-day drop on soft guidance last year. Note also that management guides conservatively in wide ranges and has raised the annual outlook twice already this year, so the bar for the next print is higher again.

    Two dates for the calendar: Applied unveils its new EPIC Center on October 12 and hosts an investor presentation October 13 at SEMICON West, where it plans to give a longer-term outlook.

    Bottom line: AI infrastructure is becoming a return-on-capital contest. A big order book is not a moat; a repeatable margin structure is. Don't confuse a healthy industry with a healthy stock — but do notice when the market punishes a record quarter.

    3) Biotech M&A Is Moving Toward Overlooked Disease Assets

    Pharma buyers are still hunting, but the target list has narrowed. Jazz Pharmaceuticals' agreement to acquire Actio Biosciences for up to $1.32 billion — adding an experimental therapy for a rare inherited epilepsy — is the template: upfront capital for a defined clinical asset, with the balance tied to regulatory and commercial milestones.

    The structural insight is the one worth keeping: milestone payments are a confession. When a buyer pays a fraction up front and holds the rest behind future approvals, it's telling you precisely where it believes the risk lives and declining to pay for it today. The headline number gets printed; the upfront number is what the buyer actually believes. Small biotechs with narrow indications, credible data, and a strategic fit can be worth more than companies with sprawling pipelines and no financing runway — and the useful work happens early, tracking cash runways, upcoming readouts, licensing relationships, and which drugmakers face pipeline gaps.

    Bottom line: In biotech, follow the assets that solve a buyer's problem — and read the milestone structure before you treat an acquisition as validation.

    📢 Sponsor Slot — rotating content will appear here

    4) Retail Earnings Will Show Whether the Consumer Is Splitting in Two

    This week brings the main event for consumer research: Walmart, Target, Home Depot, and Lowe's all report, giving the clearest read yet on how tariffs, fuel, and food costs are landing across income groups.

    There is no single consumer, and we have the data to prove it. Inflation is running at 3.4% while wage growth is 3.2% — the fourth consecutive month in which prices have outpaced paychecks. That doesn't hit every household equally. Higher-income shoppers absorb it; lower-income shoppers trade down, shift from goods to necessities, or lean on credit. Albertsons' own chief executive told analysts last month that the company's biggest customer losses were to Walmart, Amazon, and Aldi, concentrated among price-sensitive shoppers. Murphy USA posted a 43% profit jump on fuel margins while same-store volumes rose just 0.5%. Both are the same story from different angles: the aggregate looks fine, the margin consumer is straining.

    So read the mix, not the headline. Specifically: inventory levels and shrink, private-label penetration, promotional cadence, basket size versus transaction count, and any credit-card commentary. A retailer can post respectable sales while revealing a dangerous composition — more promotions, smaller baskets, and customers who only show up for markdowns. Demand that has been rented with discounts comes due eventually.

    No pick this morning, for a mechanical reason: the four companies that will define this narrative all report within days of you reading this. Featuring one of them today means recommending a stock hours before its most important information becomes public. Read the prints, then decide — the market will still be open Thursday.

    Bottom line: Aggregate spending can look fine while the margin consumer is breaking. Read the mix, not the headline.

    5) Private Credit Is Becoming a Data Problem Before It Becomes a Default Problem

    The New York and Dallas Federal Reserve banks plan to launch a pilot survey of the private-credit market after the third quarter. That's an institutional signal worth more than most headlines: when regulators start building a better map, they've concluded the existing one isn't good enough.

    We looked at this market's numbers ten days ago, and they were not comforting — Fitch's private-credit default rate has plateaued at 6.0%, a record since the series began, with maturity extensions rather than payment defaults driving more than half of the quarter's events. But today's point is different and, in a way, more important. That earlier discussion was about what the data showed. This one is about whether the data is any good.

    Private credit has grown to enormous scale outside the daily price discovery public markets provide. Loans can be marked smoothly while the underlying borrower faces higher costs, weaker demand, or a refinancing it cannot complete. Two lenders can hold the same loan at different values. Nobody is lying — there simply isn't a tape. That's tolerable while conditions are calm and intolerable the moment they aren't, which is presumably why two regional Feds want a survey.

    The contrarian angle isn't predicting a blowup. It's recognizing that improved transparency is itself a catalyst. If the survey reveals tighter terms or weaker marks than assumed, the repricing won't be limited to private lenders — it will touch the banks that finance them, the insurers that own the paper, and the levered small companies that borrowed from them, all at once. Ask who owns the risk, who values it, and who gets paid first when a deal stops working. "Private" doesn't mean safer. It often means slower information.

    Bottom line: Transparency is the next private-credit catalyst. When the data improves, the winners and losers will separate quickly.

    Before You Go

    The market is calm because the headlines are cooperating. Calm markets encourage leverage and lazy assumptions — and Friday gave us a preview of what happens when the assumptions get tested. A company posted the best quarter in its 60-year history, raised its outlook, and lost 5% of its value in a morning.

    That's not a broken market. That's a market that has repriced the cost of being merely excellent.

    So here's the question for Monday: if this rally is durable, why does it still require a quiet Fed, cheap Japanese funding, flawless AI capital spending, and a consumer who keeps paying full price? Any one of those can wobble without a recession. Two of them wobbling at once is what a correction looks like.

    Own businesses that survive the wobble.

    Found this helpful? Share it with others.

    Written by Behind the Markets